Change search criteria ↓

Search results

7 projects found matching your search criteria:

  1. 1. Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell the…

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

    Call: PRELUDIUM BIS 3, Panel: NZ5

  2. 2. Heterogeneity immunocompetent cells during chimeric antigen receptor T cell (CAR-T) CD19 immunotherapy.

    Principal investigator: Aleksandra Maria Oszer

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ6

  3. 3. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 22, Panel: NZ7

  4. 4. Identification of surface proteins as alternate targets for CAR-T therapy against CD19-negative tumors.

    Principal investigator: dr hab. Magdalena Hanna Winiarska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM BIS 2, Panel: NZ6

  5. 5. Identification of circulating biomarkers for monitoring anti-CD19 CAR-T cell treatment response in patients with aggress…

    Principal investigator: Monika Szelest

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 23, Panel: NZ5

  6. 6. Identification and characterization of omics profiles in patients' serum during anti-CD19 CAR-T cell therapy

    Principal investigator: Jaromir Bartosz Tomasik

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 23, Panel: NZ5

  7. 7. B regulatory cells (CD19+CD24+CD38+) in nephropathy exacerbation in the course of systemic lupus erythematosus.

    Principal investigator: dr Joanna Katarzyna Kosałka-Węgiel

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: PRELUDIUM 13, Panel: NZ5

Graphic design and implementation: Jakub Piotrowski